Sun Pharma introduces anti-cancer product in Europe

Posted on:12 Jul 2016 11:53:48
Sun Pharma introduces anti-cancer product in Europe
12 July 2016 Current Affairs: Sun Pharmaceutical Industries announced rollout of Gemcitabine InfuSMART, on Monday, used in treatment of cancer, in Europe.

Sun Pharma has announced rollout of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a ready-to-administer (RTA) bag.

Sun Pharma's Gemcitabine InfuSMART ready-to-administer infusion products provide the combined advantage of long stable compounded medicine along with safety... Traditionally, such medicines are compounded at hospitals (in-house) or outsourced to compounding pharmacies, making it a time-consuming and potentially hazardous process.

Launch of InfuSMART will help us remain a meaningful player in the global oncology therapy market by offering differentiating cancer treatment solutions. We believe there are opportunities for us to expand our portfolio of ready-to-administer products across multiple therapies where time and safety are an important element of treatment.

Sun Pharma has received regulatory approval to produce Gemcitabine InfuSMART in eight key SKUs (stock keeping units).

More InfuSMART oncology products are currently in Sun Pharma's pipeline to be rolled out in future.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs November 2017

22 NOVEMBER
NEWS
21 NOVEMBER
NEWS
20 NOVEMBER
NEWS
19 NOVEMBER
NEWS

Current Affairs October 2017

31 OCTOBER
NEWS
30 OCTOBER
NEWS
29 OCTOBER
NEWS
28 OCTOBER
NEWS

Current Affairs September 2017

30 SEPTEMBER
NEWS
28 SEPTEMBER
NEWS
27 SEPTEMBER
NEWS
26 SEPTEMBER
NEWS